298. Breast Cancer: Perimeter Medical’s AI Platform Slashes Re-Excisions and Costs in Breast Cancer Treatment

Episode breakdown:00:00 – Tech Problems, AV Chaos, and Starting the Conversation 00:50 – Meet Adrian Mendes, CEO of Perimeter Medical 01:27 – How Perimeter Got on the Radar (and Chamath’s Backing) 02:17 – Chamath Explains the Breast Cancer Surgery Problem 04:47 – AI + Imaging to Eliminate Repeat Surgeries 06:34 – FDA Trials, Labeling, and the Road to Approval 07:23 – The Emotional and Clinical Impact of Re-Excisions 08:35 – How Surgeons Use Perimeter’s Current FDA-Cleared Device 09:52 – $700M Wasted Annually on Repeat Surgeries 10:59 – Cutting Re-Excisions to 5%: Hospital and Patient Benefits 12:07 – Why Medtech Needs Both Clinical and Economic Pathways 12:58 – Adrian’s AI Hardware Background and Move to Medtech 14:55 – How Optical Coherence Tomography (OCT) Works in the OR 16:27 – Imaging Comparison: OCT vs. Ultrasound vs. MRI vs. Pathology 17:59 – Building an AI + OCT Platform and Tissue Registry 19:22 – The Scale of the Market Opportunity Beyond Breast Cancer 20:55 – Why Breast Cancer Was the Beachhead Market 21:53 – Perimeter’s Business Model: Capital, Disposables, and AI Software 23:33 – Adoption, Workflow Integration, and Surgeon Response 25:49 – Confidence, Data, and Surgeon Feedback 27:02 – Demand Creation and Word-of-Mouth Growth 28:59 – Workflow Demo: How the Device Is Used in Surgery 30:49 – Patient Impact: Rural Access and Reduced Delays 32:31 – AI Levels the Playing Field for Community Hospitals 33:53 – PMA Submission and AI Clinical Trial Results (88.1% Accuracy) 35:57 – The Emotional Benefit of “First-Time-Right” Cancer Surgery 37:20 – Regulatory Progress and Commercial Updates 38:44 – Chamath’s Involvement and Why AI Differentiates Perimeter 40:05 – Quality Data vs. Big Data: Building a Proprietary Library 41:13 – Predictive Health, Earlier Detection, and Future Applications 42:24 – TechMed vs. Medtech: Why Perimeter Is a True Hybrid 43:07 – Looking Ahead: More Indications and Expanding Applications 43:53 – Closing Thoughts and Call to ActionAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfgSubscribe to our LinkedIn Newsletterhttps://www.stateofmedtechpodcast.com/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtechInstagram https://www.instagram.com/stateofmedtech/TikTok https://www.tiktok.com/@stateofmedtechX https://twitter.com/StateofMedTechFacebook https://www.facebook.com/stateofmedtech/Follow Omar M. Khateeb onLinkedIn https://www.linkedin.com/in/okhateeb/Instagram https://www.instagram.com/omar.m.khateeb/TikTok https://www.tiktok.com/@omarkhateebofficialX https://twitter.com/OmarMKhateebFacebook https://www.facebook.com/OmarMKhateeb/This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.